"market cap @ $0.075 in 2018: $15.8M
market cap end of this week @ $0.075: $38.5M
dilution on steroids... "
That's true, but back then they had no cash. Biotechs need cash. Since then $15m raised at least.
The company now has plenty of cash to see it through to the results of the current ptx100 trial, and that's all I care about to be honest. Even though any of the CART-T, ptx200 and COVID 19 projects could be worth heaps.
Just concentrate on ptx100 (ptx 100c)
cheers
Ann: Completion of $6.5 million Share Purchase Plan, page-24
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
